|
|
 |
|
Viewing report
|
|
|
|
Oxford Handbook of Cancer Epidemiology and Prevention, Third Edition
Oxford University Press, Aug 2006, Pages: 1,416
This much anticipated Third Edition provides a comprehensive presentation of the global burden and patterns of cancer occurrence, along with new developments in our understanding of cancer causation and prevention. Special attention is given to epidemiologic approaches that incorporate molecular biomarkers based on genomic and other emerging technologies, providing new insights into the role of genetic predisposition and gene-environment interactions in cancer induction. In addition, new chapters are included on social class disparities in cancer incidence and mortality, the role of obesity and physical inactivity in cancer etiology, the potential effects of electromagnetic fields and radiofrequency radiation, and principles of cancer chemoprevention.
The textbook is organized into five sections: Basic Concepts; The Magnitude of Cancer; The Causes of Cancer; Cancer By Tissue of Origin; Cancer Prevention and Control. In this new edition, Drs. David Schottenfeld and Joseph F. Fraumeni, Jr. have enlisted three distinguished Associate Editors: Drs. Jonathan Samet of Johns Hopkins University, Graham Colditz of Harvard University and Alice Whittemore of Stanford University.
About the Authors
Edited by David Schottenfeld, John G. Searle Professor of Epidemiology, University of Michigan School of Public Health (Emeritus) , and Joseph F. Fraumeni, Jr., Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute
Customers who bought this item also bought
The Cancer Clock
Cancer Therapeutics Markets
Cancer Chemotherapy: Basic Science to the Clinic
Imaging Tools in Cancer Research and Prevention
Looking at the Cancer Therapy Market
Lung Cancer, 3rd Edition
Lynn Sage Breast Cancer Symposium
Cancer Therapeutics - Market Insight and R&D Pipeline Analysis
Viral Therapy of Cancer
Drug Delivery in Cancer - Technologies, Markets and Companies
European Bladder Cancer Therapeutics Markets
Prostate Cancer Therapeutics - Global Strategic Business Report
|
|
|
|
